GlassScriptPhysician profile
Erin D Lott
NPI 1851621056
$8,605.69
in general payments reported to CMS, 2019-2025
72 companies · $2,146 in 2025
The $2,146 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,310 · 2022: $1,536 · 2023: $1,977 · 2024: $1,638 · 2025: $2,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,261 · Long Term Medical Supply Or Device Loan: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,261.41 |
| Long Term Medical Supply Or Device Loan | $498.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,199.01 | 2021-2025 | Kisqali, Piqray |
| Merck Sharp & Dohme LLC | $665.69 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $485.90 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| E.R. Squibb & Sons, L.L.C. | $425.84 | 2021-2025 | Opdivo, Opdualag, Krazati |
| Pfizer INC. | $339.39 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $338.43 | 2021-2025 | Iclusig, Alunbrig, Ninlaro |
| Lilly USA, LLC | $265.33 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Kite Pharma, INC. | $224.27 | 2021-2025 | Yescarta |
| Genzyme Corporation | $221.12 | 2021-2024 | |
| Array Biopharma INC | $216.79 | 2021-2025 | Mektovi, Braftovi, Tukysa |
| Rigel Pharmaceuticals, INC. | $202.61 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Genentech USA, INC. | $201.22 | 2021-2025 | Venclexta, Tecentriq, Lunsumio |
| Regeneron Healthcare Solutions, INC. | $198.53 | 2021-2025 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $195.29 | 2021-2025 | Calquence, Enhertu |
| Abbvie INC. | $182.09 | 2021-2025 |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $172.36 | 2021-2025 | |
| Amgen INC. | $168.92 | 2021-2023 | Kyprolis, Nplate, Xgeva |
| Seagen INC. | $156.89 | 2021-2023 | Tukysa |
| Incyte Corporation | $151.49 | 2021-2025 | Jakafi, Pemazyre, Monjuvi |
| Karyopharm Therapeutics INC. | $146.74 | 2021-2025 | Xpovio |
| Glaxosmithkline, LLC. | $146.32 | 2021-2025 | Jemperli, Zejula, Ojjaara |
| Eisai INC. | $137.16 | 2021-2023 | |
| Celgene Corporation | $119.23 | 2022-2025 | Reblozyl, Pomalyst |
| Adc Therapeutics America, INC. | $117.60 | 2022-2025 | |
| Gilead Sciences, INC. | $111.26 | 2022-2024 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $109.42 | 2022-2025 | |
| Servier Pharmaceuticals LLC | $103.26 | 2023-2025 | |
| Daiichi Sankyo INC. | $103.12 | 2021-2025 | Injectafer |
| Ipsen Biopharmaceuticals, INC | $87.35 | 2022-2025 | Onivyde, Somatuline Depot |
| Asd Specialty Healthcare, LLC | $85.16 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.08 | 2021-2025 | |
| Tersera Therapeutics LLC | $68.98 | 2021-2025 | Xermelo, Zoladex |
| Puma Biotechnology, INC. | $63.12 | 2021-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $62.49 | 2021-2023 | Imbruvica |
| Astellas Pharma US INC | $55.45 | 2023-2025 | Xtandi, Cresemba |
| Geron Corporation | $53.94 | 2025 | Rytelo |
| Legend Biotech USA INC. | $51.08 | 2025 | Carvykti |
| Taiho Oncology, INC. | $50.99 | 2022-2024 | |
| Beigene USA, INC. | $42.22 | 2021-2023 | Brukinsa |
| Sobi, INC | $39.04 | 2024 | |
| Iovance Biotherapeutics, INC. | $35.87 | 2025 | Amtagvi |
| G1 Therapeutics, INC. | $35.36 | 2022-2023 | Cosela |
| Stemline Therapeutics INC. | $34.89 | 2024 | Orserdu |
| Morphosys, US INC. | $33.43 | 2023 | Monjuvi |
| Emd Serono, INC. | $32.46 | 2022-2023 | Bavencio |
| Sumitomo Pharma America, INC. | $28.66 | 2023 | Orgovyx |
| Adaptive Biotechnologies Corporation | $28.00 | 2023 | Clonoseq |
| Secura Bio, INC. | $27.13 | 2021 | |
| Pharmacosmos Therapeutics INC. | $26.51 | 2024 | Monoferric |
| Blueprint Medicines Corporation | $26.25 | 2024 | Ayvakit |
| Pharmaessentia USA Corporation | $25.75 | 2024 | Besremi |
| Acrotech Biopharma INC. | $25.21 | 2023 | Beleodaq |
| Fennec Pharmaceuticals, INC. | $24.97 | 2024 | Pedmark |
| Novocure INC. | $24.82 | 2024 | |
| Beone Medicines USA, INC. | $24.78 | 2025 | Tevimbra |
| Mirati Therapeutics, INC. | $24.42 | 2023 | Krazati |
| Azurity Pharmaceuticals, INC. | $23.74 | 2025 | Danziten |
| Aveo Pharmaceuticals, INC. | $23.49 | 2022 | |
| Forte Bio-Pharma LLC | $23.20 | 2023 | Prolate, Nalocet |
| Genmab U.S., INC. | $22.06 | 2025 | Epkinly |
| Organon LLC | $21.44 | 2021 | |
| Medtronic, INC. | $20.62 | 2022 | |
| Deciphera Pharmaceuticals INC. | $20.08 | 2023 | Qinlock |
| Cycle Pharmaceuticals INC | $19.63 | 2025 | Phyrago |
| Tolmar, INC. | $18.89 | 2023 | |
| Dova Pharmaceuticals | $17.94 | 2021 | |
| Progenics Pharmaceuticals, INC. | $16.83 | 2025 | |
| Alexion Pharmaceuticals, INC. | $16.59 | 2024 | Ultomiris |
| Recordati_rare_diseases_inc. | $15.48 | 2025 | Sylvant |
| Exelixis INC. | $13.48 | 2023 | Cabometyx |
| Sun Pharmaceutical Industries INC. | $12.80 | 2021 | |
| Cti Biopharma Corp. | $12.73 | 2022 |
Drugs and devices associated with these payments
Kisqali $728Keytruda $431Opdivo $223Tavalisse $190Rezlidhia $190Scemblix $186Verzenio $174Mektovi $167Braftovi $167Yescarta $162Jaypirca $149Imbruvica $145Tukysa $140Zepzelca $118Paxlovid $109Piqray $106Libtayo $103Venclexta $102Jakafi $93.57Prolate $92.80Zejula $86.65Jemperli $86.65Lynparza $85.85Darzalex $85.31Injectafer $80.16Welireg $71.98Tecvayli $68.57Onivyde $66.79Sarclisa $64.00Epkinly $63.61Jevtana $63.14Reblozyl $62.14Monjuvi $59.59Tibsovo $59.51Calquence $58.80Iclusig $57.66Xofigo $56.40Nubeqa $56.40Elrexfio $55.50Rytelo $53.94Xpovio $53.40Retevmo $51.28Carvykti $51.08Lenvima $48.56Eliquis $48.39Nurtec Odt $48.39Xtandi $47.83Enhertu $46.97Somatuline Depot $46.02Inlyta $45.45Ojjaara $44.85Talvey $44.73Comirnaty $42.47Lorbrena $41.44Krazati $40.45Zynlonta $40.43Synagis $39.04Kyprolis $37.14Opdualag $36.82Ibrance $36.18Amtagvi $35.87Orserdu $34.89Bosulif $34.86Tecentriq $34.57Alunbrig $31.44Xermelo $31.36Orgovyx $28.66Padcev $28.61Xalkori $28.29Clonoseq $28.00Trodelvy $27.42Ninlaro $27.06Monoferric $26.51Ayvakit $26.25Pemazyre $26.16Besremi $25.75Beleodaq $25.21Pedmark $24.97Tevimbra $24.78Cresemba $24.46Brukinsa $24.39Keytruda Qlex $24.18Danziten $23.74Pomalyst $23.45Nalocet $23.20Tasigna $22.96Columvi $22.67Polivy $22.67Lunsumio $22.67Fabhalta $22.56Stivarga $21.41Gavreto $20.98Fruzaqla $20.64Zoladex $20.63Qinlock $20.08Phyrago $19.63Adcetris $19.61Exkivity $19.20Nplate $19.17Voranigo $19.17
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Lott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.